Full Text View
Tabular View
No Study Results Posted
Related Studies
Clonidine as Adjunct Therapy for the Treatment of Neonatal Abstinence Syndrome (NAS)
This study has been completed.
Study NCT00510016   Information provided by National Institute on Drug Abuse (NIDA)
First Received: July 31, 2007   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neonatal Abstinence Syndrome
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Disease
Disorders of Environmental Origin
Infant, Newborn, Diseases
Mental Disorders
Pathologic Processes
Substance-Related Disorders
Interventions listed in this trial
Clonidine HCL
Additional drug interventions recognized in this trial
Clonidine
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic Agonists
Adrenergic alpha-Agonists
Analgesics
Antihypertensive Agents
Autonomic Agents
Cardiovascular Agents
Central Nervous System Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Sympatholytics
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
Johns Hopkins University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services